{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T23:37:08Z","timestamp":1772494628255,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM008792"],"award-info":[{"award-number":["T32GM008792"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"William Stamps Farish Fund"},{"name":"Howell Family Foundation"},{"name":"James H. \"Red\" Duke Professorship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The TRPM4 gene codes for a membrane ion channel subunit related to inflammation in the central nervous system. Recent investigation has identified an association between TRPM4 single nucleotide polymorphisms (SNPs) rs8104571 and rs150391806 and increased intracranial (ICP) pressure following traumatic brain injury (TBI). We assessed the influence of these genotypes on clinical outcomes and ICP in TBI patients. We included 292 trauma patients with TBI. DNA extraction and real-time PCR were used for TRPM4 rs8104571 and rs150391806 allele discrimination. Five participants were determined to have the rs8104571 homozygous variant genotype, and 20 participants were identified as heterozygotes; 24 of these 25 participants were African American. No participants had rs150391806 variant alleles, preventing further analysis of this SNP. Genotypes containing the rs8104571 variant allele were associated with decreased Glasgow outcome scale-extended (GOSE) score (<jats:italic>P<\/jats:italic>\u2009=\u20090.0231), which was also consistent within our African-American subpopulation (<jats:italic>P<\/jats:italic>\u2009=\u20090.0324). Regression analysis identified an association between rs8104571 variant homozygotes and mortality within our overall population (<jats:italic>P<\/jats:italic>\u2009=\u20090.0230) and among African Americans (<jats:italic>P<\/jats:italic>\u2009=\u20090.0244). Participants with rs8104571 variant genotypes exhibited an overall increase in ICP (<jats:italic>P<\/jats:italic>\u2009=\u20090.0077), although a greater frequency of ICP measurements\u2009&gt;\u200925\u00a0mmHg was observed in wild-type participants (<jats:italic>P<\/jats:italic>\u2009=\u2009\u2009&lt;\u20090.0001). We report an association between the TRPM4 rs8104571 variant allele and poor outcomes following TBI. These findings can potentially be translated into a precision medicine approach for African Americans following TBI utilizing TRPM4-specific pharmaceutical interventions. Validation through larger cohorts is warranted.<\/jats:p>","DOI":"10.1038\/s41598-023-32819-7","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T09:02:54Z","timestamp":1681117374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Influence of TRPM4 rs8104571 genotype on intracranial pressure and outcomes in African Americans with traumatic brain injury"],"prefix":"10.1038","volume":"13","author":[{"given":"Joseph D.","family":"Krocker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeline E.","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob B.","family":"Schriner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baron K.","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Talanker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Wei W.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Charles S.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles E.","family":"Wade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,10]]},"reference":[{"key":"32819_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jsr.2012.08.011","volume":"43","author":"VG Coronado","year":"2012","unstructured":"Coronado, V. G. et al. Trends in traumatic brain injury in the U.S. and the public health response: 1995\u20132009. J. Saf. Res. 43, 299\u2013307. https:\/\/doi.org\/10.1016\/j.jsr.2012.08.011 (2012).","journal-title":"J. Saf. Res."},{"key":"32819_CR2","unstructured":"Surveillance Report: Traumatic Brain Injury-related Deaths by Age Group, Sex, and Mechanism of Injury. https:\/\/www.cdc.gov\/traumaticbraininjury\/pdf\/TBI-surveillance-report-2018-2019-508.pdf (2019)."},{"key":"32819_CR3","doi-asserted-by":"publisher","unstructured":"Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18, 56\u201387. https:\/\/doi.org\/10.1016\/s1474-4422(18)30415-0 (2019).","DOI":"10.1016\/s1474-4422(18)30415-0"},{"key":"32819_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00701-017-3118-z","volume":"159","author":"E Picetti","year":"2017","unstructured":"Picetti, E. et al. Intracranial pressure monitoring after primary decompressive craniectomy in traumatic brain injury: A clinical study. Acta Neurochir. (Wien) 159, 615\u2013622. https:\/\/doi.org\/10.1007\/s00701-017-3118-z (2017).","journal-title":"Acta Neurochir. (Wien)"},{"key":"32819_CR5","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s00134-015-3806-1","volume":"41","author":"F Guiza","year":"2015","unstructured":"Guiza, F. et al. Visualizing the pressure and time burden of intracranial hypertension in adult and paediatric traumatic brain injury. Intensive Care Med. 41, 1067\u20131076. https:\/\/doi.org\/10.1007\/s00134-015-3806-1 (2015).","journal-title":"Intensive Care Med."},{"key":"32819_CR6","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1007\/s00134-012-2655-4","volume":"38","author":"S Badri","year":"2012","unstructured":"Badri, S. et al. Mortality and long-term functional outcome associated with intracranial pressure after traumatic brain injury. Intensive Care Med. 38, 1800\u20131809. https:\/\/doi.org\/10.1007\/s00134-012-2655-4 (2012).","journal-title":"Intensive Care Med."},{"key":"32819_CR7","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3171\/2010.11.Jns101116","volume":"114","author":"A Farahvar","year":"2011","unstructured":"Farahvar, A. et al. Response to intracranial hypertension treatment as a predictor of death in patients with severe traumatic brain injury. J. Neurosurg. 114, 1471\u20131478. https:\/\/doi.org\/10.3171\/2010.11.Jns101116 (2011).","journal-title":"J. Neurosurg."},{"key":"32819_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1385\/ncc:4:1:008","volume":"4","author":"M Balestreri","year":"2006","unstructured":"Balestreri, M. et al. Impact of intracranial pressure and cerebral perfusion pressure on severe disability and mortality after head injury. Neurocrit. Care 4, 8\u201313. https:\/\/doi.org\/10.1385\/ncc:4:1:008 (2006).","journal-title":"Neurocrit. Care"},{"key":"32819_CR9","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.3171\/sup.1991.75.1s.0s59","volume":"75","author":"A Marmarou","year":"1991","unstructured":"Marmarou, A. et al. Impact of ICP instability and hypotension on outcome in patients with severe head trauma. J. Neurosurg. 75, S59\u2013S66. https:\/\/doi.org\/10.3171\/sup.1991.75.1s.0s59 (1991).","journal-title":"J. Neurosurg."},{"key":"32819_CR10","unstructured":"American College of Surgeons. ACS TQIP Best Practices in the Management of Traumatic Brain Injury. https:\/\/www.facs.org\/media\/mkej5u3b\/tbi_guidelines.pdf (2015)."},{"key":"32819_CR11","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1038\/jcbfm.2012.91","volume":"32","author":"JM Simard","year":"2012","unstructured":"Simard, J. M., Woo, S. K., Schwartzbauer, G. T. & Gerzanich, V. Sulfonylurea receptor 1 in central nervous system injury: A focused review. J. Cereb. Blood Flow Metab. 32, 1699\u20131717. https:\/\/doi.org\/10.1038\/jcbfm.2012.91 (2012).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"32819_CR12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/nen.0000000000000223","volume":"74","author":"RI Mehta","year":"2015","unstructured":"Mehta, R. I. et al. Sur1-Trpm4 cation channel expression in human cerebral infarcts. J. Neuropathol. Exp. Neurol. 74, 835\u2013849. https:\/\/doi.org\/10.1097\/nen.0000000000000223 (2015).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"32819_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/glia.23231","volume":"66","author":"JA Stokum","year":"2018","unstructured":"Stokum, J. A. et al. SUR1-TRPM4 and AQP4 form a heteromultimeric complex that amplifies ion\/water osmotic coupling and drives astrocyte swelling. Glia 66, 108\u2013125. https:\/\/doi.org\/10.1002\/glia.23231 (2018).","journal-title":"Glia"},{"key":"32819_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12974-015-0432-3","volume":"12","author":"TK Makar","year":"2015","unstructured":"Makar, T. K. et al. Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis. J. Neuroinflamm. 12, 210. https:\/\/doi.org\/10.1186\/s12974-015-0432-3 (2015).","journal-title":"J. Neuroinflamm."},{"key":"32819_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195526","volume":"13","author":"V Gerzanich","year":"2018","unstructured":"Gerzanich, V., Kwon, M. S., Woo, S. K., Ivanov, A. & Simard, J. M. SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells. PLoS ONE 13, e0195526. https:\/\/doi.org\/10.1371\/journal.pone.0195526 (2018).","journal-title":"PLoS ONE"},{"key":"32819_CR16","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00701-019-03936-y","volume":"161","author":"PJ Hutchinson","year":"2019","unstructured":"Hutchinson, P. J. et al. Consensus statement from the international consensus meeting on the role of decompressive craniectomy in the management of traumatic brain injury: Consensus statement. Acta Neurochir. (Wien) 161, 1261\u20131274. https:\/\/doi.org\/10.1007\/s00701-019-03936-y (2019).","journal-title":"Acta Neurochir. (Wien)"},{"key":"32819_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/neuros\/nyaa278","volume":"87","author":"GWJ Hawryluk","year":"2020","unstructured":"Hawryluk, G. W. J. et al. Guidelines for the management of severe traumatic brain injury: 2020 Update of the decompressive craniectomy recommendations. Neurosurgery 87, 427\u2013434. https:\/\/doi.org\/10.1093\/neuros\/nyaa278 (2020).","journal-title":"Neurosurgery"},{"key":"32819_CR18","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1089\/neu.2018.6124","volume":"36","author":"RM Jha","year":"2019","unstructured":"Jha, R. M. et al. Downstream TRPM4 polymorphisms are associated with intracranial hypertension and statistically interact with ABCC8 polymorphisms in a prospective cohort of severe traumatic brain injury. J. Neurotrauma 36, 1804\u20131817. https:\/\/doi.org\/10.1089\/neu.2018.6124 (2019).","journal-title":"J. Neurotrauma"},{"key":"32819_CR19","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gkz836","volume":"48","author":"S Fairley","year":"2019","unstructured":"Fairley, S., Lowy-Gallego, E., Perry, E. & Flicek, P. The International Genome Sample Resource (IGSR) collection of open human genomic variation resources. Nucleic Acids Res. 48, D941\u2013D947. https:\/\/doi.org\/10.1093\/nar\/gkz836 (2019).","journal-title":"Nucleic Acids Res."},{"key":"32819_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/HTR.0b013e3181d36ca3","volume":"25","author":"JC Arango-Lasprilla","year":"2010","unstructured":"Arango-Lasprilla, J. C. & Kreutzer, J. S. Racial and ethnic disparities in functional, psychosocial, and neurobehavioral outcomes after brain injury. J. Head Trauma Rehabil. 25, 128\u2013136. https:\/\/doi.org\/10.1097\/HTR.0b013e3181d36ca3 (2010).","journal-title":"J. Head Trauma Rehabil."},{"key":"32819_CR21","doi-asserted-by":"publisher","first-page":"R119","DOI":"10.1093\/hmg\/ddab004","volume":"30","author":"K Esoh","year":"2021","unstructured":"Esoh, K. & Wonkam, A. Evolutionary history of sickle-cell mutation: Implications for global genetic medicine. Hum. Mol. Genet. 30, R119-r128. https:\/\/doi.org\/10.1093\/hmg\/ddab004 (2021).","journal-title":"Hum. Mol. Genet."},{"key":"32819_CR22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-physiol-021119-034345","volume":"82","author":"DJ Friedman","year":"2020","unstructured":"Friedman, D. J. & Pollak, M. R. APOL1 and kidney disease: From genetics to biology. Annu. Rev. Physiol. 82, 323\u2013342. https:\/\/doi.org\/10.1146\/annurev-physiol-021119-034345 (2020).","journal-title":"Annu. Rev. Physiol."},{"key":"32819_CR23","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1177\/1060028018779082","volume":"52","author":"A Helmer","year":"2018","unstructured":"Helmer, A., Slater, N. & Smithgall, S. A review of ACE inhibitors and ARBs in black patients with hypertension. Ann. Pharmacother. 52, 1143\u20131151. https:\/\/doi.org\/10.1177\/1060028018779082 (2018).","journal-title":"Ann. Pharmacother."},{"key":"32819_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020409","author":"RM Jha","year":"2020","unstructured":"Jha, R. M. et al. Role of sulfonylurea receptor 1 and glibenclamide in traumatic brain injury: A review of the evidence. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21020409 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"32819_CR25","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1097\/01.CCM.0000220765.22184.ED","volume":"34","author":"PM Shore","year":"2006","unstructured":"Shore, P. M. et al. Reliability and validity of the Pediatric Intensity Level of Therapy (PILOT) scale: A measure of the use of intracranial pressure-directed therapies. Crit. Care Med. 34, 1981\u20131987. https:\/\/doi.org\/10.1097\/01.CCM.0000220765.22184.ED (2006).","journal-title":"Crit. Care Med."},{"key":"32819_CR26","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.jpedsurg.2019.06.022","volume":"55","author":"BF Flaherty","year":"2020","unstructured":"Flaherty, B. F. et al. Ability of the PILOT score to predict 6-month functional outcome in pediatric patients with moderate-severe traumatic brain injury. J. Pediatr. Surg. 55, 1238\u20131244. https:\/\/doi.org\/10.1016\/j.jpedsurg.2019.06.022 (2020).","journal-title":"J. Pediatr. Surg."},{"key":"32819_CR27","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1089\/neu.2020.7527","volume":"38","author":"L Wilson","year":"2021","unstructured":"Wilson, L. et al. A manual for the Glasgow outcome scale-extended interview. J. Neurotrauma 38, 2435\u20132446. https:\/\/doi.org\/10.1089\/neu.2020.7527 (2021).","journal-title":"J. Neurotrauma"},{"key":"32819_CR28","unstructured":"Qiagen. Purification of archive-quality DNA from clotted whole blood using the Gentra Puregene Tissue Kit or Gentra Puregene Mouse Tail Kit. (2010). https:\/\/www.qiagen.com\/us\/resources\/resourcedetail?id=5038cce2-32bb-4772-8dd0-94993dfc00b6&lang=en."},{"key":"32819_CR29","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1089\/neu.2021.0356","volume":"39","author":"DA Zuckerman","year":"2022","unstructured":"Zuckerman, D. A., Giacino, J. T. & Bodien, Y. G. Traumatic brain injury: What is a favorable outcome?. J. Neurotrauma 39, 1010\u20131012. https:\/\/doi.org\/10.1089\/neu.2021.0356 (2022).","journal-title":"J. Neurotrauma"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32819-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32819-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32819-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T10:10:21Z","timestamp":1681121421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32819-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,10]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["32819"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-32819-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,10]]},"assertion":[{"value":"15 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Wade holds a financial interest in Decisio Health Inc., is a consultant to CellPhire, and has patents licensed through The University of Texas to Decisio Health and Grifols. Dr. Cox receives support from the following organizations: National Institutes of Health; Department of Defense-Medical Technology Enterprise Consortium; State of Texas Emerging Technology Fund; Generate Life Sciences, Inc.; Athersys, Inc.; Celgene Cellular Therapeutics; Cellvation, Inc.; Cellularity, Inc.; Hope Biosciences, Inc.; The Bentsen Foundation; Mission Connect; Let's Cure CP; Ladybug Foundation; Evelyn Griffin Foundation; Glassell Family Foundation; The George and Cynthia Mitchell Foundation; Grace R. Walls Endowment; Brown Foundation; Cellvation, Inc.; Coagulex, Inc.; EMIT Corporation. These affiliations are unrelated to the present work, and these funders were not involved in the study design, data collection, data analysis, data interpretation, manuscript authorship, or the decision to publish. The other authors report no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5815"}}